Effect of glucocorticoid-induced osteoporotic-like conditions on osteoblast cell attachment to implant surface microtopographies

Implant Dentistry

Volumn 15, Issue 4, 2006, Pages 377-385

  Cho, Peter ^a   Schneider, Galen B ^a   Kellogg, Bradley ^a,b   Zaharias, Rebecca ^a   Keller, John C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

Focal adhesion kinase; Glucocorticoids; Implants; Osteoblasts; Osteoporosis

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BETA-GLYCEROPHOSPHORIC ACID; DEXAMETHASONE; FOCAL ADHESION KINASE; GLUCOCORTICOID; GLYCEROL 2 PHOSPHATE; GLYCEROPHOSPHATE; TITANIUM; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CELL STRAIN 3T3; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; IMMUNOPRECIPITATION; MOUSE; OSTEOBLAST; OSTEOPOROSIS; PATHOLOGY; PHOSPHORYLATION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TOOTH IMPLANTATION; WESTERN BLOTTING;

3T3 CELLS; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CELL PROLIFERATION; DENTAL IMPLANTS; DEXAMETHASONE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GLUCOCORTICOIDS; GLYCEROPHOSPHATES; HUMANS; IMMUNOPRECIPITATION; MICE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; OSTEOPOROSIS; PHOSPHORYLATION; SURFACE PROPERTIES; TITANIUM; TYROSINE;

EID: 33845753848     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000247858.37697.d5     Document Type: Article

References (12)

1. Fujimoto T, Atsushi N, Naki H, et al. Osseointegrated implants in a patient with osteoporosis: A Case Report. Int J Oral and Maxillofac Implants. 1996;11:539-542.
2. Riggs BI, Melton LJ III. Involutional osteoporosis. N Engl J Med. 1986;314:1676-1686.
3. Mori H, Manabe M, Kurachi Y, et al. Osseointegration of dental implants in rabbit bone with low mineral density. J Oral Max Surg. 1997;55:351-361.
4. Kribbs PJ. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dent. 1990;63:218-222.
5. Patschan D. Loddenkemper K, Buttgereit F. Molecular mechanism of glucocorticoid-induced osteoporosis. Bone. 2001;29:498-505.
6. Lian J, Shaloub B, Aslam V, et al. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down regulates osteocalcin gene expression. Endocrinology. 1997;138:2117-2127.
7. Perinpanayagam H. Zaharias R, Stanford CM, et al. Early cell adhesion events differ between osteoporotic and non-osteoporotic osteoblasts. J Orthop Res. 2001;19:993-1000.
8. Bowers KT, Keller JC, Randolph BA, et al. Optimization of surface micromorphology for enhanced osteoblast responses in vitro. Int J Oral Maxillofac Implants. 1992;7:303-310.
9. Keller JC, Draughn RA, Wightman JP, et al. Characterization of sterilized cpTi implant surfaces. Int J Oral Maxillofac Implants. 1990;5:360-367.
10. Schneider GB, Perinpanayagam H, Clegg M, et al. Implant surface roughness affects osteoblast gene expression. J Dent Res. 2003;82:372-376.
11. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754.
12. Ren X, Kiosses W, Sieg D, et al. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci. 2000;113:3673-3681.